KLOW Blend

GHK-Cu / BPC-157 / TB-500 / KPV | Regenerative System

Technical card

System

Regenerative System
Type

Multi-peptide blend — 4 components
Components

GHK-Cu │ BPC-157 │ TB-500 │ KPV
Form

Lyophilized vial
Purity

>98% per component by HPLC
Status

Active
Blend Studies

Not available in current indexed literature

View Research Library

Access to the catalog is structured — not open by default.

How Access Works Already have access? Sign In

Technical card

System

Regenerative System
Type

Multi-peptide blend — 4 components
Components

GHK-Cu │ BPC-157 │ TB-500 │ KPV
Form

Lyophilized vial
Purity

>98% per component by HPLC
Status

Active
Blend Studies

Not available in current indexed literature

View Research Library

KLOW Blend Overview

The KLOW Blend is a four-component research formulation within AXION’s Regenerative System. It is not a supplement and not a protocol. It is a research design decision: a single vial engineered to enable the simultaneous investigation of four mechanistically distinct pathways within the regenerative cascade.

Each component enters the cascade at a different point. GHK-Cu acts at the level of extracellular matrix remodeling and collagen synthesis signaling. BPC-157 engages the vascular axis via VEGFR2/eNOS, with documented pleiotropic effects across multiple repair contexts. TB-500 acts on actin dynamics and cell migration through the Tb4–MRTF-A pathway. KPV modulates the inflammatory environment at the level of NF-κB transcription, with 47 indexed publications at the time of this document.

The rationale for combining these four compounds is not synergy — there is no published evidence demonstrating combined potentiation. The rationale is complementarity of phase: each peptide occupies a non-overlapping position in the regenerative sequence, and none of their primary mechanisms are redundant.

KLOW Blend Research Directions

GHK-Cu:
– Collagen and elastin synthesis — TGF-β1 upregulation, fibronectin and laminin production in fibroblast models
– Extracellular matrix remodeling — differential regulation of MMPs and TIMPs across wound contexts
– Antioxidant signaling — Nrf2 pathway activation and SOD/catalase upregulation in oxidative stress models
– Wound repair — angiogenesis promotion and keratinocyte migration in skin models
– Neurotrophin expression — BDNF and NGF upregulation in neuronal research contexts
BPC-157:
– Musculoskeletal repair — tendon, ligament, muscle, and bone physiology in rodent preparations
– Vascular function and angiogenesis — VEGFR2/eNOS axis, vasomotor tone, ischemia/reperfusion models
– Gastrointestinal and mucosal protection — ulcer, colitis, fistula, and NSAID-induced mucosal damage models
– Tendon fibroblast migration — FAK-paxillin phosphorylation and ECM remodeling
– Neuroprotection — spinal cord injury models, ischemic stroke, dopaminergic system interactions
TB-50:
– Cell migration — actin sequestration and MRTF-A nuclear translocation driving SRF-dependent gene expression
– Musculoskeletal repair — tendon, muscle, and connective tissue models
– Angiogenesis — endothelial cell migration and tube formation via actin-dependent mechanisms
– Anti-inflammatory signaling — downregulation of inflammatory mediators in injury models
KP:
– NF-κB inhibition — suppression of pro-inflammatory transcription in gut epithelial and skin models (47 indexed publications)
– Cytokine modulation — reduction of IL-6, IL-8, and TNF-α in inflammatory research contexts
– Mucosal integrity — investigated in colitis and intestinal barrier models
– Melanocortin receptor activity — MC1R and MC3R binding, derived from C-terminal of α-MSH

The KLOW Blend was formulated to enable the simultaneous investigation of four complementary regenerative pathways within a single experimental model. Published studies on this specific combination are not available in the current indexed literature. The scientific references for each component are individually documented and available on their respective molecule pages. AXION documents what exists and what does not — this is the standard.

KLOW Blend Quality & Traceability

Every AXION compound is subject to analytical verification before release. Purity and traceability are not marketing attributes — they are part of the integrity of the research itself.

Certificate of Analysis

Available per lot on request. Issued per component.
Lot Traceability

Each vial carries a unique lot number linked to its full analytical record.
QR Verification

QR code on packaging links directly to the COA for that specific lot.
HPLC Verified

>98% purity per component per lot. Verified by HPLC + Mass Spectrometry.
Blend composition

Component ratios available in Product Access upon authorization.

Learn more about our verification process: Quality & Testing